Keros Therapeutics, Inc. Common Stock (KROS) News

Latest headlines that mention KROS, newest first · each headline opens the original publisher

KROS quote

Last price: $11.64
Day change: +3.84%
Next earnings: 2026-11-04

Quote & chart Expected move Insider trading IV rank history

KROS headlines

latest coverage

Investing.com 9d ago

Keros Therapeutics to receive $20M milestone from Takeda

General T3KROS TAK

Seeking Alpha 1mo ago

Keros Therapeutics launches $5M share buyback after $20M milestone

General T2KROS

Investing.com 1mo ago

Keros Therapeutics director Bienaime buys $10,270 in shares

General T3KROS

Yahoo Finance 1mo ago

Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?

General T2KROS TAK

Investing.com 2mo ago

Keros to receive $20 million milestone from Takeda partnership

General T3KROS TAK

Investing.com 3mo ago

Keros Therapeutics appoints Anne Prener to board of directors

General T3KROS

Seeking Alpha News 4mo ago

Keros Therapeutics, Inc. (KROS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

General T2KROS

Investing.com 4mo ago

Keros Therapeutics director Nima sells $28,166 in company stock

General T3KROS

Investing.com 4mo ago

Keros earnings missed by $0.18, revenue fell short of estimates

Earnings T3KROS

Seeking Alpha 4mo ago

Keros Therapeutics GAAP EPS of -$1.21 misses by $0.19, revenue of $0.37M misses by $1.32M

Earnings T2KROS

Also mentioned with KROS

30d

TAK1

Headlines that tag both tickers

KROS news alerts

Get an alert by email or push when a new headline mentions KROS.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.